Interaction between CTLA4 gene and IBD5 locus in Hungarian Crohn's disease patients

Veronika Csöngei1, Luca Járomi, Eniko Sáfrány

  • 1Department of Medical Genetics, University of Pécs, Pécs, Szigeti út 12, H-7624, Hungary.

Insights

Specific combinations of IBD5 and CTLA4 gene variants increase Crohn's disease risk in Hungarian patients. The IGR2198a_1 and IGR2096a_1 variants, when combined with the CTLA4 +49 AA genotype, significantly elevate susceptibility.

Area of Science:

  • Genetics
  • Immunology
  • Gastroenterology

Background:

  • IBD5 gene region variants IGR2198a_1 and IGR2096a_1 are linked to Crohn's disease (CD) in Hungarians.
  • The IGR2230a_1 variant shows no disease association.
  • The cytotoxic T lymphocyte antigen-4 (CTLA4) +49 A/G substitution was previously found to be neutral in Hungarian CD patients.

Purpose of the Study:

  • To investigate the statistical interaction between IBD5 polymorphisms (IGR2198a_1, IGR2096a_1, IGR2230a_1) and the CTLA4 +49 A/G substitution.
  • To determine if specific genotype combinations influence Crohn's disease risk.

Main Methods:

  • Genotyping of 305 unrelated Crohn's disease patients and 310 healthy controls.
  • Utilized Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) for genotyping.

Main Results:

  • The IGR2198a_1 C and IGR2096a_1 T variants conferred susceptibility to CD only in individuals with the CTLA4 +49 AA genotype (P = 0.008; OR = 1.86 and P = 0.016; OR = 1.74, respectively).
  • No significant disease risk effect was demonstrated for the IGR2230a_1 variant, even in combination with CTLA4 genotypes.

Conclusions:

  • Specific genotype combinations of IBD5 and CTLA4 variants are associated with Crohn's disease risk.
  • The findings suggest a potential interaction between CTLA4 +49 A/G substitution and certain IBD5 variants in disease susceptibility.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...